How should antibodies against P. falciparum merozoite antigens be measured?

Research output: Contribution to journalReview article

Abstract

Immunity against malaria develops slowly and only after repeated exposure to the parasite. Many of those that die of the disease are children under five years of age. Antibodies are an important part of immunity, but which antibodies that are protective and how these should be measured are still unclear. We discuss the pros and cons of ELISA, invasion inhibition assays/ADCI, and measurement of affinity of antibodies and what can be done to improve these assays, thereby increasing the knowledge about the immune status of an individual, and to perform better evaluation of vaccine trials.

Details

Authors
External organisations
  • Karolinska Institutet
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Immunology in the medical area

Keywords

  • antibody, antigen, malaria vaccine, merozoite antigen, unclassified drug
Original languageEnglish
Article number493834
JournalJournal of Tropical Medicine
Publication statusPublished - 2013
Publication categoryResearch
Peer-reviewedYes
Externally publishedYes

Total downloads

No data available